Business Context and Reporting Period
This Form 8-K Current Report was filed by Insulet Corporation on December 20, 2016, covering events occurring on December 14, 2016. The filing addresses corporate governance and executive compensation matters rather than operational or financial performance results.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly informational regarding the amendment of the Executive Severance Plan.
Material Changes
The primary material change reported is the amendment and restatement of the Company's Executive Severance Plan by the Compensation Committee. The updated plan applies to officers at the rank of Vice President or higher ("Covered Executives") and outlines specific benefits upon termination without "cause" or resignation for "good reason."
- Base Salary Severance: 1x annual base salary (2x for the CEO).
- Annual Bonus Severance: 1x target or actual bonus (applicable to Presidents, SVPs, and EVPs).
- Pro Rata Bonus: Applicable to Presidents, SVPs, and EVPs based on performance metrics.
- Health Benefits: Continued coverage for 12 months (24 months for the CEO).
- Outplacement Services: Reimbursement up to $15,000 ($25,000 for senior executives).
Change in Control Provisions: If termination occurs within 24 months of a change in control, severance multiples increase to 2x for eligible executives, and all outstanding stock options and awards immediately accelerate.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future business performance. The document defines "good reason" for resignation as a material diminution of responsibilities, a material reduction in base salary, or relocation of the principal office more than 50 miles. The full text of the Severance Plan is filed as Exhibit 10.1.
Investor Verification Checklist
- Review Exhibit 10.1 for the complete legal text of the Amended and Restated Executive Severance Plan.
- Verify the specific definitions of "cause" and "good reason" within the plan to understand termination triggers.
- Confirm the list of current "Covered Executives" eligible under the new plan terms.
- Assess the potential financial impact of the accelerated stock option provisions in the event of a change in control.